BioSpace News Archive

Therapy Brands is pleased to welcome and announce Ryan Anschuetz as the Vice President of Sales.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Wednesday, September 25, 2019 at 9:00 p.m. EDT/2:00 a.m. IST (September 26, 2019) to provide investors with a business update, including data being presented on JZP-258 and solriamfetol at the World Sleep Congress, to be held in Vancouver, B.C. September 20-25, 2019.

First FDA Approved Trifocal Lens Allows Cataract Patients to See Clearly

On September 5, 2019, the BC government announced phase two of its Biosimilars Initiative, informing patients prescribed the originator biologic drug, Remicade® (infliximab), to treat inflammatory bowel disease (Crohn’s disease and ulcerative colitis) that this medication will no longer be covered by the province, and that they must switch to a biosimilar infliximab, either Inflectra® or Renflexis®

Pact Includes Staffing Improvements, Wage Increases and Participation in Defined Benefit Pension Plan to Improve Recruitment and Retention of Nurses and to Ensure Quality Patient Care

Fuse Medical, Inc. announced that it has been ranked number 137 on the 2019 list of Dallas-Fort Worth’s 150 largest public companies, by the Dallas Morning News.

St. Jude launches Paws at Play hospital dog program to help pediatric patients cope with the challenges of treatment and hospitalization.

INTELLiSTEM Technologies, an international company revolutionizing stem cell medicine, today announced that they have created genetically engineered Super Sentinel Cells™ (SSC’s) to effectively target cancer cells.

BioTheryX, Inc. (“BioTheryX”), a biotechnology company creating new classes of drugs for unmet medical needs based on multi-kinase inhibition and targeted protein degradation, today announced the appointment of Jeffrey Edwards to its board of directors.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care, oncology and specialty pharmacists, will host the third of its 2019 Directions in Oncology Pharmacy™ fall conference series on Saturday, Oct. 19, at the Wyndham Grand Orlando Resort Bonnet Creek Hotel, in Orlando, Florida.